H & M Hennes & Mauritz AB (publ)HMSB
▲ PositiveRegulationrelevance
France's fee targets low-cost fast fashion from Shein/Temu, not H&M, which offers fewer items, potentially giving H&M a competitive advantage.
Impact on assets 4
Consumer Discretionary
H & M Hennes & Mauritz AB (publ)
Industria de Diseno Textil SAIXD1
▲ PositiveRegulationrelevance
Zara, owned by Inditex, is not expected to be subject to the fee, as it offers fewer items, potentially benefiting from reduced competition.
PDD Holdings Inc.PDD
Mentioned
Others
SHEIN Global Holdings Limited0625
▼ NegativeRegulationrelevance
France imposes fees on Shein's products, directly increasing costs and potentially reducing sales.
Theme Impact 1
Off-coverage companies
Related news
United States▲2
Lockheed Martin Raises Quarterly Dividend 4.3% to $3.60
Lockheed Martin declared a quarterly dividend of $3.60 per share, a 4.3% increase from its prior dividend of $3.45. The forward yield comes to 2.83%. The dividend is payable Dec. 31 to shareholders of record as of Dec. 1, with an ex-dividend date of Dec. 1.
About megatrends
Defense & Geopolitical Fragmentation › Defense Primes — United States ▲Capital
LMT · Capital · Positive Lockheed Martin raised its quarterly dividend 4.3% to $3.60 per share, a shareholder-return/financial event.
United States▲
Jim Cramer Recommends Staged Buying in L3Harris After Q2 Beat
Jim Cramer said he likes L3Harris Technologies and advised investors to build a position gradually rather than trying to pick a bottom, speaking during the October 7 lightning round of Mad Money. Cramer suggested buying in increments, using a $230 stock divided by 10 as a $23 stock, buying the first tranche at 23 and adding down to 20. The comments followed L3Harris's second-quarter results, which showed orders of $7.3 billion, a book-to-bill ratio of 1.2x, and a record backlog of $42 billion. Revenue rose 8% to approximately $5.9 billion, diluted EPS climbed 28% to $3.13, and free cash flow increased 37% to $771 million. Missile Solutions revenue grew 14% to approximately $1.05 billion, while Communications & Spectrum Dominance operating margin rose to 26.9% from 24.6%. Cramer's interest comes even as L3Harris trades at approximately 18.7x forward earnings, above Lockheed Martin at 16.5x and Northrop Grumman at 16.6x, and as hedge fund holders slipped to 56 in Q2 from 59 in Q1.
About megatrends
Defense & Geopolitical Fragmentation › Defense Primes — United States ▲Capital
Defense & Geopolitical Fragmentation › Defense Electronics, EW & Sensors ▲Capital
Defense & Geopolitical Fragmentation › Missiles & Precision-Guided Munitions ▲Capital
Defense & Geopolitical Fragmentation › Space Defense & Missile Warning ▲Capital
Defense & Geopolitical Fragmentation › Missiles, Munitions & Energetics ▲Capital
United States▲impact 4
Raytheon Wins Navy Missile Contracts Worth Up To $30.7 Billion
Raytheon, an RTX business, has secured multi-year U.S. Navy contracts worth up to US$24.40 billion for Standard Missile-6 interceptors and up to US$6.30 billion for Standard Missile-3 Block IB interceptors, alongside additional awards tied to rising global missile defense demand. The long-term missile production and sustainment deals deepen RTX's role in critical air and missile defense infrastructure and reinforce its extensive backlog. The five-year Standard Missile 6 contract in particular supports RTX's backlog-driven investment case and ties into management's plan to spend about US$10.0 billion to US$10.5 billion in 2026 on engineering and capital projects aimed at easing missile capacity constraints and improving margins over time. RTX's narrative projects $112.3 billion in revenue and $10.9 billion in earnings by 2029, requiring 6.3% yearly revenue growth and a $3.2 billion earnings increase from $7.7 billion today. Three Simply Wall St community fair value estimates for RTX span roughly US$215.80 to US$234.82 per share, with the forecasts implying a $234.82 fair value and a 27% upside to the current price.
About megatrends
Defense & Geopolitical Fragmentation › Missiles & Precision-Guided Munitions ▲Demand
Defense & Geopolitical Fragmentation › Defense Primes — United States ▲Demand
Defense & Geopolitical Fragmentation › Missiles, Munitions & Energetics ▲Demand
RTX · Demand · Positive Raytheon won multi-year U.S. Navy contracts worth up to $30.7B for SM-6 and SM-3 Block IB interceptors, deepening its missile defense backlog.
RTX · Capital · Positive The contracts support RTX's backlog-driven investment case and its plan to spend ~$10-10.5B in 2026 on engineering and capital projects to ease missile capacity constraints and improve margins.
United States▲2impact 4
RTX Wins $20.7 Billion AMRAAM Contract as Cramer Flags Commercial Aviation Risk
RTX's Raytheon business announced an AMRAAM production contract valued at up to $20.7 billion on September 28, covering five years with two option years and supporting a substantial increase in missile production. The maximum contract value should not be confused with revenue already earned. RTX also reported second-quarter sales of approximately $24.7 billion, up 14%, and adjusted earnings per share of $1.89, up 21%, with a backlog of $289 billion split between $170 billion in commercial orders and $119 billion in defense orders, and management raised its full-year adjusted EPS outlook to $7.10 - $7.25 from $6.70 - $6.90. On Mad Money, Jim Cramer said RTX keeps getting contract after contract despite fears that the defense budget has peaked, but he warned that weakness in commercial aerospace, where airlines could cut plane purchases if oil stays high, remains a complication. Pratt & Whitney's latest quarterly commercial aftermarket sales rose 25% even as commercial original-equipment sales fell 8%, and RTX continues to absorb costs from the Pratt & Whitney powder-metal issue, with its second-quarter filing estimating an approximately $700 million cash impact in 2026. At approximately 24.9x forward earnings, RTX traded below GE Aerospace's 36.9x but above Lockheed Martin's 16.6x, while 92 hedge funds held the stock in the second quarter versus 95 in the first, and short interest stood at 1.01% of the float.
About megatrends
Defense & Geopolitical Fragmentation › Defense Primes — United States ▲Demand
Defense & Geopolitical Fragmentation › Missiles & Precision-Guided Munitions ▲Demand
Defense & Geopolitical Fragmentation › Missiles, Munitions & Energetics ▲Demand
Aerospace & Aviation › Aircraft Engines & Propulsion Demand
RTX · Capital · Positive Q2 sales rose 14% to ~$24.7B, adjusted EPS up 21% to $1.89, and management raised full-year adjusted EPS guidance to $7.10-$7.25.
RTX · Demand · Positive Raytheon won a $20.7 billion AMRAAM production contract covering five years with two option years, supporting a substantial increase in missile production.
RTX · Supply · Negative RTX continues to absorb costs from the Pratt & Whitney powder-metal issue, with an estimated ~$700 million cash impact in 2026.
United StatesBarclays Initiates SpaceX at Overweight With $254 Price Target
Barclays initiated coverage of SpaceX with an Overweight rating and a $254 price target, part of a broad rollout of coverage across the aerospace and defense group in which the firm said the U.S. is in the "early innings of a modern day industrial revolution." In the same sweep, Barclays started RTX, Palantir, Kratos Defense, Karman, DPC Holdings, CAE, Beta Technologies and Rocket Lab at Overweight, Planet Labs, FireFly Aerospace, AeroVironment, York Space Systems and Lockheed Martin at Equal Weight, and Northrop Grumman at Underweight. Among other calls, Baird upgraded Humana to Outperform from Neutral with a price target of $596, up from $390, citing greater confidence in the company's $35-plus of 2028 adjusted earnings per share power, while Morgan Stanley double upgraded Cboe Global Markets to Overweight from Underweight with a price target of $358, up from $258. On the downgrade side, JPMorgan cut DuPont to Neutral from Overweight with a price target of $145, down from $172, and removed the stock from its Analyst Focus List, and also downgraded Illinois Tool Works to Neutral from Overweight with a price target of $270, down from $350, both on concerns around decelerating short cycle industrial demand into 2027. Citi downgraded Pershing Square Inc. to Sell from Neutral with an unchanged price target of $45 on valuation, and RBC Capital downgraded Knife River to Sector Perform from Outperform with a price target of $58, down from $103. Other initiations included Truist starting IBM at Hold with a $240 price target, Citi starting Fortune Brands at Buy with a $48 price target, Freedom Broker starting Ultra Clean at Buy with a $127 price target, and JPMorgan resuming Trane at Overweight with a $550 price target.
About megatrends
Space Economy › Launch Services & Propulsion ▲Capital
Defense & Geopolitical Fragmentation › Defense Primes — United States Capital
KNF · Capital · Negative RBC Capital downgraded Knife River to Sector Perform from Outperform and cut its price target to $58 from $103.
KRMN · Capital · Positive Barclays initiated Karman at Overweight as part of its aerospace and defense coverage rollout.
KTOS · Capital · Positive Barclays initiated Kratos Defense at Overweight in its aerospace and defense coverage sweep.
LMT · Capital · Neutral Barclays started Lockheed Martin at Equal Weight, a neutral rating.
NOC · Capital · Negative Barclays initiated Northrop Grumman at Underweight.
SPCX · Capital · Positive Barclays initiated SpaceX at Overweight with a $254 price target.
United StatesJ.P. Morgan Downgrades Leidos to Neutral, Cuts Price Target to $142
J.P. Morgan downgraded Leidos Holdings to Neutral from Overweight and lowered its price target to $142 from $160, citing deteriorating earnings expectations tied to weakness in the company's healthcare business. The new target still implies roughly 25% upside from Leidos' Oct. 7 closing price of $113.55, but analyst Seth M. Seifman said the company's relatively low valuation is not enough to justify an Overweight rating when other aerospace and defense stocks offer substantial potential returns. J.P. Morgan forecasts Leidos' 2027 revenue at approximately $18.1 billion, down from an estimated $18.35 billion in 2026, with adjusted ebitda falling to $2.14 billion from $2.45 billion and adjusted ebitda margin declining to 11.8% from 13.3%, largely on Health segment margins projected to drop to 16% from 22%. Seifman noted that Bloomberg consensus estimates still anticipate approximately $2.45 billion in adjusted ebitda for 2027, suggesting published expectations may be too optimistic. In the same Oct. 8 research report, J.P. Morgan named Howmet Aerospace, Honeywell Aerospace, Huntington Ingalls Industries and Lockheed Martin as potential outperformers this earnings season, while keeping Overweight ratings on Boeing with a $290 price target and StandardAero with a $40 price target.
About megatrends
Defense & Geopolitical Fragmentation › Defense Primes — United States Capital
Defense & Geopolitical Fragmentation › Defense Software & C4ISR Capital
LDOS · Capital · Negative J.P. Morgan downgraded Leidos to Neutral and cut its price target to $142, citing deteriorating earnings expectations and weak healthcare margins.
BA · Capital · Positive J.P. Morgan kept an Overweight rating on Boeing with a $290 price target, naming it a potential earnings-season outperformer.
HII · Capital · Positive J.P. Morgan named Huntington Ingalls as a potential outperformer this earnings season.
HONA · Capital · Positive J.P. Morgan named Honeywell Aerospace among potential outperformers this earnings season while keeping its Overweight-rated aerospace names.
HWM · Capital · Positive J.P. Morgan named Howmet Aerospace as a potential outperformer this earnings season.
SARO · Capital · Positive J.P. Morgan kept an Overweight rating on StandardAero with a $40 price target.